Applied DNA Sciences Inc (NASDAQ:APDN) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 1,590,000 shares, a growth of 12.0% from the September 30th total of 1,420,000 shares. Based on an average daily trading volume, of 415,300 shares, the short-interest ratio is presently 3.8 days. Approximately 4.6% of the shares of the company are sold short.
Shares of Applied DNA Sciences stock traded down $13.95 during trading on Wednesday, hitting $5.05. 317,612 shares of the company’s stock traded hands, compared to its average volume of 76,363. Applied DNA Sciences has a 1 year low of $4.20 and a 1 year high of $49.56. The business has a 50-day simple moving average of $1.72 and a 200-day simple moving average of $0.77.
Applied DNA Sciences (NASDAQ:APDN) last released its quarterly earnings data on Tuesday, August 13th. The technology company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.02. Applied DNA Sciences had a negative return on equity of 1,284.19% and a negative net margin of 221.66%. The company had revenue of $2.05 million for the quarter.
In other Applied DNA Sciences news, major shareholder William W. Montgomery acquired 400,000 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The shares were bought at an average cost of $0.27 per share, with a total value of $108,000.00. Following the completion of the transaction, the insider now directly owns 5,630,900 shares of the company’s stock, valued at approximately $1,520,343. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 22.42% of the company’s stock.
An institutional investor recently bought a new position in Applied DNA Sciences stock. Capital Investment Advisors LLC acquired a new stake in shares of Applied DNA Sciences Inc (NASDAQ:APDN) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 53,500 shares of the technology company’s stock, valued at approximately $27,000. Capital Investment Advisors LLC owned about 0.15% of Applied DNA Sciences at the end of the most recent reporting period.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.
Featured Article: Understanding each part of a balance sheet
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.